Comunicação social | HIPRA

who we are

Comunicação social

2023-07-17 14:43

AEMPS authorizes the clinical trial to study the joint vaccination of HIPRA's COVID-19 vaccine with an influenza vaccine

Humana

2023-05-29 08:15

AEMPS authorizes the clinical trial to study HIPRA's COVID-19 vaccine in adolescents between 12 and 17 years old

Humana

2023-04-11 16:57

The Spanish Prime Minister defines HIPRA’s vaccine as a 'historic milestone' that reinforces the country's leadership in the European health sector

Humana

2023-03-31 14:27

BIMERVAX® has also obtained the approval of the European Commission to be marketed

Humana

2023-03-30 16:00

HIPRA receives positive opinion from European Medicines Agency for its BIMERVAX® COVID-19 Vaccine

Humana

2023-01-17 14:29

HIPRA’s COVID-19 vaccine trial in people with immunocompromising conditions was launched in Turkey

Humana